[Erythropoietin Treatment May Improve Cognition in Neuropsychiatric Disorders]

Ugeskr Laeger. 2017 Aug 14;179(33):V01170037.
[Article in Danish]

Abstract

Cognitive dysfunction is a core feature in a range of neuropsychiatric disorders which reduces patients' workforce capacity - the largest socio-economic cost of these disorders. Nevertheless, there is no clinically available medical treatment with robust and enduring efficacy on cognitive deficits in most neuropsychiatric conditions. Recent research has shown that erythropoietin may have beneficial effects on cognitive dysfunction across neuropsychiatric disorders, including bipolar and unipolar disorders, schizophrenia, Parkinson's disease and multiple sclerosis.

Publication types

  • Review

MeSH terms

  • Bipolar Disorder / drug therapy
  • Cognition / drug effects*
  • Cognitive Dysfunction / drug therapy*
  • Erythropoietin / administration & dosage
  • Erythropoietin / therapeutic use*
  • Humans
  • Mood Disorders / drug therapy
  • Multiple Sclerosis / drug therapy
  • Parkinson Disease / drug therapy
  • Schizophrenia / drug therapy

Substances

  • Erythropoietin